Paul Siami

2.2k citations

30 papers · 1.5k indexed · 1 hit paper · h-index 16

Impact in

Urology top 0.2%
- Urinary Bladder and Prostate Research
- Urological Disorders and Treatments
Rheumatology top 1%
- Pelvic floor disorders treatments

Papers in

Urology 23
- Urinary Bladder and Prostate Research 22
Rheumatology 11
- Pelvic floor disorders treatments 10

Co-authors: Claus G. Roehrborn Jack Barkin Betsy Morrill Francesco Montorsi Ronaldo Damião Kim Major‐Walker R. Paul Gagnier Indrani Nandy
Journals: Urology (6 papers)British Journal of Urology (4 papers)The Journal of Urology (3 papers)Journal of the American Geriatrics Society (2 papers)Prostate Cancer and Prostatic Diseases (2 papers)
Partner nations: United States Italy Canada

In The Last Decade

Paul Siami

28 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study 2009 · 528 citations

Peers

Countries citing papers authored by Paul Siami

Since Specialization

Citations

This map shows the geographic impact of Paul Siami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Siami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Siami more than expected).

Fields of papers citing papers by Paul Siami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Siami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Siami. The network helps show where Paul Siami may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Siami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Siami Line = papers co-authored together Paul Siami links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: Long‐term results from the combination of dutasteride and tamsulosin study International Journal of Urology ·Byung Ha Chung, Seung Hwan Lee, Claus G. Roehrborn, Paul Siami, Kim Major‐Walker, Timothy H. Wilson, Francesco Montorsi, (unknown)	2012	10
2	Once‐daily trospium chloride 60 mg extended‐release provides effective, long‐term relief of overactive bladder syndrome symptoms Neurourology and Urodynamics ·Norman R. Zinner, Roger R. Dmochowski, David Staskin, Paul Siami, Peter K. Sand, Michael G. Oefelein	2011	15
3	Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4‐year results from the randomized, double‐blind Combination of Avodart and Tamsulosin (CombAT) trial British Journal of Urology ·Claus G. Roehrborn, Jack Barkin, Paul Siami, Andrea Tubaro, Timothy H. Wilson, Betsy Morrill, R. Paul Gagnier	2011	81
4	The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study European Urology ·Claus G. Roehrborn, Paul Siami, Jack Barkin, Ronaldo Damião, Kim Major‐Walker, Indrani Nandy, Betsy Morrill, R. Paul Gagnier, Francesco Montorsi Hit paper breakdown →	2009	528
5	The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study Prostate Cancer and Prostatic Diseases ·Alpay Tuncar, Claus G. Roehrborn, Paul Siami, R. Paul Gagnier, Selene Guadalupe Carballo Zumaya, Francesco Montorsi, (unknown)	2009	29
6	Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder Urology ·Roger R. Dmochowski, Kenneth M. Peters, Jon D. Morrow, Zhonghong Guan, Jason Gong, Franklin Sun, Paul Siami, David Staskin	2009	78
7	The Influence of Baseline Parameters on Changes in International Prostate Symptom Score with Dutasteride, Tamsulosin, and Combination Therapy among Men with Symptomatic Benign Prostatic Hyperplasia and an Enlarged Prostate: 2-Year Data from the CombAT Study European Urology ·Claus G. Roehrborn, Paul Siami, Jack Barkin, Ronaldo Damião, Edgardo Becher, B. Miñana, Vincenzo Mirone, Ramiro Castro, Timothy H. Wilson, Francesco Montorsi	2008	69
8	Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: Results of a 12-week, multicenter, open-label, flexible-dose study Clinical Therapeutics ·Michael B. Chancellor, Norman R. Zinner, Kristene Whitmore, Kathleen C. Kobashi, Jeffrey A. Snyder, Paul Siami, Mickey M. Karram, Marián Hurta, 昭朗荘司, Raafat Seifeldin, 栄吾伊藤, Indrani Nandy	2008	45
9	MP-20.16: Safety and tolerability of dutasteride, tamsulosin and a combination of dutasteride and tamsulosin: Two-year results from the Combination of Avodart® and Tamsulosin (CombAT) study Urology ·Sitthiphong Thipphawan, Paul Siami, Jack Barkin, Ronaldo Damião, Francesco Montorsi	2007	1
10	MP-20.28: Dutasteride provides greater improvement in symptoms and Qmax than tamsulosin in men with moderate-to-severe symptoms of BPH and prostate enlargement: Two-year results from the Combination of Avodart® and Tamsulosin (CombAT) study Urology ·Claus G. Roehrborn, Paul Siami, Jack Barkin, Ronaldo Damião, Francesco Montorsi	2007	2
11	Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart® and Tamsulosin) trial rationale and study design Contemporary Clinical Trials ·Paul Siami, Claus G. Roehrborn, Jack Barkin, Ronaldo Damião, Gurinder Saini, Annette Duggan, Kim Major‐Walker, Betsy Morrill	2007	64
12	Long‐term treatment with darifenacin for overactive bladder: results of a 2‐year, open‐label extension study British Journal of Urology ·François Haab, Jacques Corcos, Paul Siami, Karin Glavind, Peter Dwyer, Michael Steel, van Herwijnen R, K. Lheritier, William D. Steers	2006	38
13	Long‐term sustained improvement in symptoms of benign prostatic hyperplasia with the dual 5α‐reductase inhibitor dutasteride: results of 4‐year studies British Journal of Urology ·Claus G. Roehrborn, O Lukkarinen, Stephen Mark, Paul Siami, Joe Ramsdell, Norman R. Zinner	2005	45
14	A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: The speed of onset of therapeutic assessment trial (STAT) Clinical Therapeutics ·Paul Siami, Larry Seidman, Daniel Lama	2002	45
15	Efficacy and Safety of Ciprofloxacin Oral Suspension Versus Trimethoprim‐Sulfamethoxazole Oral Suspension for Treatment of Older Women with Acute Urinary Tract Infection Journal of the American Geriatrics Society ·Irving H. Gomolin, Paul Siami, Jonathan Reuning‐Scherer, Daniel Haverstock, Allen Heyd, Qi-wen	2001	21
16	Efficacy and Safety of Ciprofloxacin Oral Suspension Versus Trimethoprim-Sulfamethoxazole Oral Suspension for Treatment of Older Women with Acute Urinary Tract Infection Journal of the American Geriatrics Society ·Irving H. Gomolin, Paul Siami, Jonathan Reuning‐Scherer, Daniel Haverstock, Allen Heyd, Qi-wen	2001	26
17	Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction Urology ·Eugene Dula, 澤祥, Paul Siami, Anthony Edmonds, Janet O’Neil, Susan M. Buttler	2000	78
18	Phase I-II evaluation of intravesical novantrone (mitoxantrone) in superficial bladder cancer Anti-Cancer Drugs ·Roohollah Sharifi, Migyung Lee, Syahlan Syahlan, Damon G. Lamb, Paul Siami, Alex Giladi, D.J. Albert, Michael Sarosdy	1991	5
19	'Acute on chronic' effect of depot leuprolide in patients with stage D2 cancer of prostate Anti-Cancer Drugs ·Roohollah Sharifi, Mark S. Soloway, Syahlan Syahlan, Assaad M. Mounzer, Alex Giladi, Paul Siami, Dan S Sem	1990	4
20	BCG in management of transitional cell carcinoma invasive to prostate Urology ·Paul Siami, E.I Bonetti, Syahlan Syahlan, V. Ray, Marvin Rubenstein, Patrick Guinan	1989	1

About Paul Siami

Paul Siami is a scholar working on Urology, Rheumatology, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (22 papers), Prostate Cancer Diagnosis and Treatment (15 papers), Hormonal and reproductive studies (12 papers), Pelvic floor disorders treatments (10 papers), Urinary Tract Infections Management (6 papers), Bladder and Urothelial Cancer Treatments (4 papers), Pharmacology and Obesity Treatment (2 papers) and Sexual function and dysfunction studies (2 papers). The work is most often cited by research in Urology (1.3k citations), Rheumatology (665 citations), Endocrinology, Diabetes and Metabolism (437 citations), Pulmonary and Respiratory Medicine (691 citations) and Psychiatry and Mental health (176 citations). Paul Siami has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Claus G. Roehrborn, Jack Barkin, Betsy Morrill, Francesco Montorsi, Ronaldo Damião, Kim Major‐Walker, R. Paul Gagnier, Indrani Nandy, Timothy H. Wilson and Daniel Lama. Their work appears in journals such as Urology, British Journal of Urology, The Journal of Urology, Journal of the American Geriatrics Society and Prostate Cancer and Prostatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact